Status:

COMPLETED

Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

Lead Sponsor:

Procter and Gamble

Conditions:

Normal Healthy Subject Population

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.

Eligibility Criteria

Inclusion

  • Normal subjects who are 18-65 years of age;
  • Non-childbearing potential females or those using birth control

Exclusion

  • History of significant GI disease
  • Any significant medical illness
  • History of hypersensitivity, allergy or intolerance to omeprazole or other proton pump inhibitors;
  • Currently using GI medications
  • GI disorder or surgery leading to impaired drug absorption

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00808769

Start Date

November 1 2008

End Date

December 1 2008

Last Update

June 1 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Research Site

Oklahoma City, Oklahoma, United States, 73104